Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Quietzsch · SciRah

Researcher profile · Semantic Scholar

D. Quietzsch

Share profile

D. Quietzsch — researcher profile on SciRah

h-index: 15
Works: 44
Citations: 1,210

Most-cited papers

Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.
V. Heinemann, D. Quietzsch, F. Gieseler, M. Gonnermann +16 more
2006Journal of Clinical Oncology686 citations Open access
Semantic Scholar
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.
S. Boeck, K. Weigang-Köhler, M. Fuchs, E. Kettner +10 more
2006Annals of Oncology76 citations Open access
Semantic Scholar
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer
F. Honecker, C. Kollmannsberger, D. Quietzsch, C. Haag +7 more
2002Anti-Cancer Drugs51 citations
Semantic Scholar
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.
Ludwig Fischer von Weikersthal, A. Schalhorn, M. Stauch, D. Quietzsch +16 more
2011European Journal of Cancer50 citations
Semantic Scholar
Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment)
D. Modest, C. Schulz, L. V. von Weikersthal, D. Quietzsch +7 more
2014Anti-Cancer Drugs48 citations Open access
Semantic Scholar
Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5‐FU/LV plus irinotecan or irinotecan plus oxaliplatin as first‐line treatment (FIRE 1‐trial)
A. Stähler, V. Heinemann, C. Gießen-Jung, A. Crispin +13 more
2016International Journal of Cancer33 citations Open access
Semantic Scholar
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
C. Bokemeyer, J. Hartmann, C. Lampe, Michael R. Clemens +3 more
1997Seminars in Oncology33 citations
Semantic Scholar
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
M. Haas, S. Ormanns, Sibylle Baechmann, Anna Remold +14 more
2017British Journal of Cancer30 citations Open access
Semantic Scholar
Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer
A. Stahler, V. Heinemann, J. Neumann, A. Crispin +15 more
2017Anti-Cancer Drugs23 citations
Semantic Scholar
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer.
J. Hartmann, D. Quietzsch, T. Daikeler, C. Kollmannsberger +3 more
1999Anti-Cancer Drugs23 citations
Semantic Scholar
RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients
R. Fahrig, D. Quietzsch, J. Heinrich, V. Heinemann +7 more
2006Anti-Cancer Drugs22 citations
Semantic Scholar
Docetaxel-cisplatin (DC) versus 5-fluorouracil-leucovorin-cisplatin (FLC) as first-line treatment for locally advanced or metastatic gastric cancer: Preliminary results of a phase III study
K. Ridwelski, J. Fahlke, E. Kettner, C. Schmidt +6 more
200522 citations
Semantic Scholar
Coronary Heart Disease Mortality, Morbidity, and Case Fatality in Five East and West German Cities 1985-1989
W. Barth, H. Löwel, M. Lewis, E. Classen +8 more
199621 citations
Semantic Scholar
Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials
S. Ormanns, M. Haas, Sibylle Baechmann, A. Altendorf-hofmann +10 more
2015British Journal of Cancer20 citations Open access
Semantic Scholar
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study
J. Hartmann, K. Oechsle, D. Quietzsch, A. Wein +7 more
2003British Journal of Cancer17 citations Open access
Semantic Scholar
Mitomycin C plus Infusional 5-Fluorouracil in Platinum-Refractory Gastric Adenocarcinoma: An Extended Multicenter Phase II Study
J. Hartmann, J. Pintoffl, S. Al-Batran, D. Quietzsch +7 more
2007Oncology Research and Treatment13 citations
Semantic Scholar
Phase III trial of irinotecan plus oxaliplatin (IROX) versus irinotecan plus 5-FU/folinic acid (FOLFIRI) as first-line treatment of metastatic colorectal cancer (CRC): The FIRE-Trial
A. Schalhorn, F. Ludwig, D. Quietzsch, P. Maubach +7 more
200513 citations
Semantic Scholar
A Multicentre Phase II Study of Docetaxel plus Cisplatin for the Treatment of Advanced Gastric Cancer
J. Fahlke, K. Ridwelski, C. Schmidt, K. Hribaschek +7 more
2007Chemotherapy9 citations
Semantic Scholar
Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice
Simone Luecke, C. Fottner, H. Lahner, H. Jann +9 more
2022Cancers6 citations Open access
Semantic Scholar
Comparison of the tumor associated proteases cathepsin D (CATH D) and urokinase-type plasminogen activator (uPA) in cytosols of human breast cancer patients.
A. Liebert, D. Quietzsch, L. Beier
1999Anticancer Research4 citations
Semantic Scholar
Second-line therapy with pemetrexed after gemcitabine failure in patients with unresectable locally advanced or metastatic pancreatic cancer: A multicenter phase II trial.
S. Boeck, K. Weigang-Koehler, Martin Fuchs, E. Kettner +6 more
2006Journal of Clinical Oncology3 citations
Semantic Scholar
A phase II pilot trial with RP101 in advanced pancreatic carcinoma.
R. Fahrig, D. Quietzsch, V. Heinemann, A. Liebert +1 more
2006Journal of Clinical Oncology2 citations
Semantic Scholar
Randomized phase III study in advanced and metastatic pancreatic cancer: single-agent gemcitabine versus gemcitabine plus cisplatin
V. Heinemann, D. Quietzsch, H. Schoenekaes, F. Gieseler +4 more
20012 citations
Semantic Scholar
Safety of adjuvant mAb 17-1A in colorectal cancer (CRC)
H. Schmoll, D. Quietzsch, P. Börner, E. Kettner +3 more
19972 citations
Semantic Scholar
Coronary heart disease mortality, morbidity, and case fatality in five east and west German cities 1985-1989. Acute Myocardial Infarction Register Teams of Augsburg, Bremen, Chemnitz, Erfurt, and Zwickau.
W. Barth, H. Löwel, M. Lewis, E. Classen +8 more
1996Journal of Clinical Epidemiology1 citations
Semantic Scholar
[Are requirements for increased safety in dealing with antineoplastic drugs exaggerated?].
N. Kusch, D. Quietzsch, S. Zimmermann
1988Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete1 citations
Semantic Scholar
SO-6 Changes in the course of advanced pancreatic cancer treatment with systemic chemotherapy: A pooled analysis of five clinical trials from two decades of clinical research within the German AIO Study-Group
L. Weiss, V. Heinemann, L. Fischer, F. Gieseler +15 more
2023Annals of Oncology0 citations Open access
Semantic Scholar
Prevalence and influence on outcome of Neuregulin- (NRG1), HER2/neu- and HER3-expression in patients with metastatic colorectal cancer (mCRC) treated with irinotecan-based first-line regimens (FUFIRI vs. mIROX) in the FIRE 1-trial
A. Stahler, V. Heinemann, C. Giessen, A. Schalhorn +9 more
20150 citations
Semantic Scholar
Early Tumor Shrinkage (ETS) For the Prediction of Efficacy in Metastatic Colorectal Cancer (MCRC): Post-Hoc Analysis from an Irinotecan-Based Randomized First-Line Trial
C. Giessen, R. Laubender, S. Stintzing, L. V. von Weikersthal +6 more
20120 citations Open access
Semantic Scholar
Contents Vol. 53, 2007
I. Spiliopoulou, Sofia Zografou, Amalia Goula, G. Dimitracopoulos +69 more
2007Chemotherapy0 citations Open access
Semantic Scholar
Subject Index Vol. 53, 2007
I. Spiliopoulou, Sofia Zografou, Amalia Goula, G. Dimitracopoulos +69 more
2007Chemotherapy0 citations Open access
Semantic Scholar
RP101 improves the efficacy of gemcitabine in treating pancreatic carcinoma.
M. Haenel, D. Quietzsch, V. Heinemann, S. Boeck +3 more
2006Journal of Clinical Oncology0 citations
Semantic Scholar
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-£uorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer
F. Honecker, C. Kollmannsberger, D. Quietzsch, C. Haag +7 more
20020 citations
Semantic Scholar
Topotecan als wöchentliche 24-Stunden-Infusion bei Patienten mit 5-Fluorouracil / Folinsäure - vorbehandelten fortgeschrittenen kolorektalen Karzinomen
D. Quietzsch, W. Baronius, P. Jungberg, A. Lievert
20000 citations
Semantic Scholar
[Antineoplastic chemotherapy in metastatic Wilm's tumor].
D. Quietzsch
1995Fortschritte der Medizin0 citations
Semantic Scholar
[The therapy of advanced breast carcinoma in men].
L. Renziehausen, D. Quietzsch
1992Deutsche Medizinische Wochenschrift0 citations
Semantic Scholar
[Variation in nocturnal blood pressure behavior in stage III (WHO) hypertension--a case report].
D. Quietzsch, A. Liebert, N. Kusch, W. Baronius +2 more
1987Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete0 citations
Semantic Scholar
[Immunomodulation with apheresis technics].
A. Liebert, D. Quietzsch, S. Zimmermann
1986Allergie und Immunologie0 citations
Semantic Scholar
[Plasma exchange therapy (plasmapheresis/plasmafiltration). II. Indications and complications].
D. Quietzsch, A. Liebert, S. Zimmermann
1984Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete0 citations
Semantic Scholar
[Plasma exchange therapy (plasmapheresis/plasma filtration). I. Technic].
A. Liebert, D. Quietzsch, S. Zimmermann
1984Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete0 citations
Semantic Scholar
[Pheochromocytoma and shock].
D. Quietzsch
1982Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete0 citations
Semantic Scholar
[Therapeutic plasmapheresis in the treatment of plasmacytoma].
D. Quietzsch, G. Kaltofen, K. Eichhorn
1981Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete0 citations
Semantic Scholar
[Iatrogenic gynecomastia in aldosterone-antagonist therapy].
D. Quietzsch
1981Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete0 citations
Semantic Scholar
[The problem-oriented case report--a method for the improvement of clinical training].
S. Zimmermann, K. Kratzsch, D. Quietzsch
1980Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Heinemann×14
Invite
V. Heinemann — researcher profile on SciRah
A. Schalhorn×9
Invite
A. Schalhorn — researcher profile on SciRah
E. Kettner×8
Invite
E. Kettner — researcher profile on SciRah
U. Vehling-Kaiser×7
Invite
U. Vehling-Kaiser — researcher profile on SciRah

×7

Invite

S. Boeck — researcher profile on SciRah

S. Zimmermann×6

Invite

S. Zimmermann — researcher profile on SciRah

Invite

M. Stauch — researcher profile on SciRah

S. Stintzing×5

Invite

S. Stintzing — researcher profile on SciRah

Invite

T. Kirchner — researcher profile on SciRah

C. Bokemeyer×5

Invite

C. Bokemeyer — researcher profile on SciRah

Invite

A. Liebert — researcher profile on SciRah

Invite

H. Lambertz — researcher profile on SciRah